On the reporting and analysis of a cancer evolutionary adaptive dosing trial

Código QR

On the reporting and analysis of a cancer evolutionary adaptive dosing trial

Guardado en:

Detalles Bibliográficos
Autor principal:	Hitesh B. Mistry
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2021
Materias:	Science Q
Acceso en línea:	https://doaj.org/article/4ab47aeb64164ca080a4352593a3c0e7
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Dynamics-Adapted Radiotherapy Dose (DARD) for Head and Neck Cancer Radiotherapy Dose Personalization
por: Mohammad U. Zahid, et al.
Publicado: (2021)

Trends in patient‐reported outcome use in early phase dose‐finding oncology trials – an analysis of ClinicalTrials.gov
por: Julia Lai‐Kwon, et al.
Publicado: (2021)

The evolutionary paradox of tooth wear: simply destruction or inevitable adaptation?
por: Stefano Benazzi, et al.
Publicado: (2013)

The Seminavis robusta genome provides insights into the evolutionary adaptations of benthic diatoms
por: Cristina Maria Osuna-Cruz, et al.
Publicado: (2020)

Evolutionary adaptations to new environments generally reverse plastic phenotypic changes
por: Wei-Chin Ho, et al.
Publicado: (2018)

Widespread adaptive evolution during repeated evolutionary radiations in New World lupins
por: Bruno Nevado, et al.
Publicado: (2016)

Untangling the evolutionary roots of lung cancer
por: Siddhartha Devarakonda, et al.
Publicado: (2019)

Quantitative assessment of sensitizing potency using a dose–response adaptation of GARDskin
por: Robin Gradin, et al.
Publicado: (2021)

Publisher Correction: Evolutionary adaptations to new environments generally reverse plastic phenotypic changes
por: Wei-Chin Ho, et al.
Publicado: (2018)

Forager and farmer evolutionary adaptations to malaria evidenced by 7000 years of thalassemia in Southeast Asia
por: Melandri Vlok, et al.
Publicado: (2021)

A randomized controlled trial of comparative effectiveness between the 2 dose and 3 dose regimens of hepatitis a vaccine in kidney transplant recipients
por: Thaninee Prasoppokakorn, et al.
Publicado: (2021)

Evolutionary trade-offs associated with loss of PmrB function in host-adapted Pseudomonas aeruginosa
por: Laura Bricio-Moreno, et al.
Publicado: (2018)

Rapid evolutionary response to a transmissible cancer in Tasmanian devils
por: Brendan Epstein, et al.
Publicado: (2016)

Ecological opportunity and adaptive radiations reveal eco-evolutionary perspectives on community structure in competitive communities
por: Mikael Pontarp
Publicado: (2021)

Evolutionary Origins of the Oligodendrocyte Cell Type and Adaptive Myelination
por: Jacob H. Hines
Publicado: (2021)

Parallel evolutionary dynamics of adaptive diversification in Escherichia coli.
por: Matthew D Herron, et al.
Publicado: (2013)

Normal tissue architecture determines the evolutionary course of cancer
por: Jeffrey West, et al.
Publicado: (2021)

Efficacy of short-term high-dose statin in preventing contrast-induced nephropathy: a meta-analysis of seven randomized controlled trials.
por: Yongchuan Li, et al.
Publicado: (2012)

Identification of optimal dosing schedules of dacomitinib and osimertinib for a phase I/II trial in advanced EGFR-mutant non-small cell lung cancer
por: Kamrine E. Poels, et al.
Publicado: (2021)

Skin gland concentrations adapted to different evolutionary pressures in the head and posterior regions of the caecilian Siphonops annulatus
por: Carlos Jared, et al.
Publicado: (2018)

Single cell RNA analysis identifies cellular heterogeneity and adaptive responses of the lung at birth
por: Minzhe Guo, et al.
Publicado: (2019)

Exploiting evolutionary steering to induce collateral drug sensitivity in cancer
por: Ahmet Acar, et al.
Publicado: (2020)

Dose-levels and first signs of efficacy in contemporary oncology phase 1 clinical trials.
por: Charles Ferte, et al.
Publicado: (2011)

Casting Light on the Adaptation Mechanisms and Evolutionary History of the Widespread Sumerlaeota
por: Yun Fang, et al.
Publicado: (2021)

An Evolutionary Link between Natural Transformation and CRISPR Adaptive Immunity
por: Peter Jorth, et al.
Publicado: (2012)

The Role of Clonal Interference in the Evolutionary Dynamics of Plasmid-Host Adaptation
por: Julie M. Hughes, et al.
Publicado: (2012)

An evolutionary frame of work to study physiological adaptation to high altitudes
por: REZENDE,ENRICO L., et al.
Publicado: (2005)

A self-adaptive prescription dose optimization algorithm for radiotherapy
por: Yin Chuou, et al.
Publicado: (2021)

A temporal shift of the evolutionary principle shaping intratumor heterogeneity in colorectal cancer
por: Tomoko Saito, et al.
Publicado: (2018)

Drug resistance missense mutations in cancer are subject to evolutionary constraints.
por: Ran Friedman
Publicado: (2013)

A single serving of mixed spices alters gut microflora composition: a dose–response randomised trial
por: Wei Wei Thwe Khine, et al.
Publicado: (2021)

Neoadjuvant T-DM1/pertuzumab and paclitaxel/trastuzumab/pertuzumab for HER2+ breast cancer in the adaptively randomized I-SPY2 trial
por: Amy S. Clark, et al.
Publicado: (2021)

Dipeptidyl peptidase-4 inhibitors, pancreatic cancer and acute pancreatitis: A meta-analysis with trial sequential analysis
por: Lana C. Pinto, et al.
Publicado: (2018)

Clonal selection confers distinct evolutionary trajectories in BRAF-driven cancers
por: Priyanka Gopal, et al.
Publicado: (2019)

Simultaneous evolutionary expansion and constraint of genomic heterogeneity in multifocal lung cancer
por: Pengfei Ma, et al.
Publicado: (2017)

Integrating evolutionary dynamics into treatment of metastatic castrate-resistant prostate cancer
por: Jingsong Zhang, et al.
Publicado: (2017)

Integrated evolutionary analysis reveals antimicrobial peptides with limited resistance
por: Réka Spohn, et al.
Publicado: (2019)

Genetic mapping and evolutionary analysis of human-expanded cognitive networks
por: Yongbin Wei, et al.
Publicado: (2019)

A low dose of risperidone resolved Charles Bonnet syndrome after an unsuccessful trial of quetiapine: a case report
por: Alamri SH
Publicado: (2018)

High-dose methotrexate-based regimens and post-remission consolidation for treatment of newly diagnosed primary CNS lymphoma: meta-analysis of clinical trials
por: Junyao Yu, et al.
Publicado: (2021)